Abanan, Mary Joy H.
HRN: 22-82-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/23/2023
CEFUROXIME 500MG (TAB)
10/23/2023
10/30/2023
PO
500mg
BID X 7 Days
S/P Primary CS; Thickly MSAF
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes